Md Sass Investors Services Has Cut By $19.53 Million Its Metlife (MET) Stake; Blackrock California Municipal 2018 Term Trust (BJZ)’s Sentiment Is 1.5

February 20, 2018 - By Matt Maslow

Md Sass Investors Services Inc decreased Metlife Inc (MET) stake by 41.49% reported in 2017Q3 SEC filing. Md Sass Investors Services Inc sold 382,995 shares as Metlife Inc (MET)’s stock declined 4.70%. The Md Sass Investors Services Inc holds 540,061 shares with $28.05 million value, down from 923,056 last quarter. Metlife Inc now has $49.06 billion valuation. The stock increased 0.86% or $0.4 during the last trading session, reaching $47.04. About 2.59 million shares traded. MetLife, Inc. (NYSE:MET) has risen 13.92% since February 20, 2017 and is uptrending. It has underperformed by 2.78% the S&P500.




The stock decreased 0.06% or $0.0089 during the last trading session, reaching $14.7311. About 11,444 shares traded. BlackRock California Municipal 2018 Term Trust (BJZ) has risen 0.05% since February 20, 2017 and is uptrending. It has underperformed by 16.65% the S&P500.

Menlo Advisors Llc holds 0.43% of its portfolio in BlackRock California Municipal 2018 Term Trust for 37,370 shares. Roundview Capital Llc owns 41,500 shares or 0.18% of their US portfolio. Moreover, Stratos Wealth Partners Ltd. has 0.02% invested in the company for 27,250 shares. The Minnesota-based Ameriprise Financial Inc has invested 0% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 244,680 shares.

Among 16 analysts covering MetLife (NYSE:MET), 9 have Buy rating, 1 Sell and 6 Hold. Therefore 56% are positive. MetLife had 49 analyst reports since July 31, 2015 according to SRatingsIntel. As per Tuesday, October 10, the company rating was downgraded by FBR Capital. RBC Capital Markets maintained the stock with “Buy” rating in Monday, October 9 report. The stock of MetLife, Inc. (NYSE:MET) earned “Equal-Weight” rating by Morgan Stanley on Friday, November 3. The firm earned “Buy” rating on Wednesday, August 2 by Wells Fargo. The stock of MetLife, Inc. (NYSE:MET) has “Sell” rating given on Thursday, January 26 by Citigroup. The rating was downgraded by Standpoint Research to “Hold” on Friday, December 9. The rating was maintained by Wells Fargo with “Buy” on Tuesday, October 3. RBC Capital Markets maintained MetLife, Inc. (NYSE:MET) rating on Friday, November 3. RBC Capital Markets has “Buy” rating and $60.0 target. The firm has “Buy” rating given on Monday, June 5 by RBC Capital Markets. The company was maintained on Thursday, December 21 by Keefe Bruyette & Woods.

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.05, from 0.94 in 2017Q2. It dropped, as 61 investors sold MET shares while 336 reduced holdings. 65 funds opened positions while 289 raised stakes. 784.85 million shares or 1.65% more from 772.09 million shares in 2017Q2 were reported. Panagora Asset Inc owns 0.01% invested in MetLife, Inc. (NYSE:MET) for 28,547 shares. Fil Ltd owns 523,097 shares. Old Natl Bancorporation In has 12,881 shares. At Bank accumulated 19,374 shares or 0.11% of the stock. The Michigan-based Monroe Comml Bank And Trust Mi has invested 0.02% in MetLife, Inc. (NYSE:MET). Archford Capital Strategies Limited Liability Company has 11,371 shares for 0.22% of their portfolio. Beacon Financial holds 0.06% of its portfolio in MetLife, Inc. (NYSE:MET) for 5,930 shares. Jnba Financial has invested 0% in MetLife, Inc. (NYSE:MET). Florida-based Aviance Capital Management Limited Liability Corp has invested 0% in MetLife, Inc. (NYSE:MET). New Jersey Better Educational Savings holds 0.44% in MetLife, Inc. (NYSE:MET) or 10,000 shares. Dynamic Advsr Solutions Limited Liability Co holds 0.15% or 7,464 shares. State Common Retirement Fund reported 2.47 million shares. Chevy Chase Trust Holdings stated it has 0.22% in MetLife, Inc. (NYSE:MET). Parametric Associate, a Washington-based fund reported 2.76 million shares. Department Mb Bank N A has invested 0% in MetLife, Inc. (NYSE:MET).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.